Literature DB >> 21292005

HIV fragment gag vaccine induces broader T cell response in mice.

Ye Liu1, Fusheng Li, Yong Liu, Kunxue Hong, Xin Meng, Jianping Chen, Zhou Zhang, Zhu Huo, Maosheng Sun, Steven G Self, Yiming Shao.   

Abstract

Broad T-cell response is considered critical for HIV-1 vaccines to compensate viral diversity. Usually, a limited number of immunodominant epitopes are recognized in natural infections, as well as in vaccinations. Here, we seek to overcome immunofocusing of CD8 T Cell responses to HIV-1 CN54 gag DNA (delivered as a plasmid) in BalB/C mice by splitting it into fragments for reducing competition of recognition between dominant and sub-dominant epitopes. As expected, mice immunized with mixture of DNA fragments elicited significantly broader T cell responses than whole-length gag. We also further studied the effects when fragments and full-length DNA vaccines are combined for prime-boost vaccination. Interestingly, mice primed with full-length gag and boosted with DNA vaccine fragments induced similar T-cell response breadth as mice both primed and boosted by fragments DNA. In contrast, mice primed with DNA vaccine fragments and boosted with full-length gag failed to broaden T cell responses, once again, only the dominant epitopes were recognized. In summary, our study demonstrated that "fragmentation strategy" can indeed broaden T cell responses. This enhancement is more likely achieved in boosting stage. This study offers a promising way to design a vaccine with higher chance covering the highly diversified circulating strains.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21292005     DOI: 10.1016/j.vaccine.2011.01.049

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  Boosting functional avidity of CD8+ T cells by vaccinia virus vaccination depends on intrinsic T-cell MyD88 expression but not the inflammatory milieu.

Authors:  Zhidong Hu; Jing Wang; Yanmin Wan; Lingyan Zhu; Xiaonan Ren; Sugan Qiu; Yanqin Ren; Songhua Yuan; Xiangqing Ding; Jian Chen; Chenli Qiu; Jun Sun; Xiaoyan Zhang; Jim Xiang; Chao Qiu; Jianqing Xu
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

2.  Vaccination with Gag, Vif, and Nef gene fragments affords partial control of viral replication after mucosal challenge with SIVmac239.

Authors:  Mauricio A Martins; Nancy A Wilson; Shari M Piaskowski; Kim L Weisgrau; Jessica R Furlott; Myrna C Bonaldo; Marlon G Veloso de Santana; Richard A Rudersdorf; Eva G Rakasz; Karen D Keating; Maria J Chiuchiolo; Michael Piatak; David B Allison; Christopher L Parks; Ricardo Galler; Jeffrey D Lifson; David I Watkins
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

3.  Novel exosome-targeted T-cell-based vaccine counteracts T-cell anergy and converts CTL exhaustion in chronic infection via CD40L signaling through the mTORC1 pathway.

Authors:  Rong Wang; Aizhang Xu; Xueying Zhang; Jie Wu; Andrew Freywald; Jianqing Xu; Jim Xiang
Journal:  Cell Mol Immunol       Date:  2016-06-06       Impact factor: 11.530

4.  Transgenic 4-1BBL-engineered vaccine stimulates potent Gag-specific therapeutic and long-term immunity via increased priming of CD44(+)CD62L(high) IL-7R(+) CTLs with up- and downregulation of anti- and pro-apoptosis genes.

Authors:  Rong Wang; Andrew Freywald; Yue Chen; Jianqing Xu; Xin Tan; Jim Xiang
Journal:  Cell Mol Immunol       Date:  2014-09-08       Impact factor: 11.530

5.  Vaccination of Macaques with DNA Followed by Adenoviral Vectors Encoding Simian Immunodeficiency Virus (SIV) Gag Alone Delays Infection by Repeated Mucosal Challenge with SIV.

Authors:  Neil Almond; Neil Berry; Richard Stebbings; Mark Preston; Claire Ham; Mark Page; Debbie Ferguson; Nicola Rose; Bo Li; Edward T Mee; Mark Hassall; Christiane Stahl-Hennig; Takis Athanasopoulos; Timos Papagatsias; Shanthi Herath; Adel Benlahrech; George Dickson; Andrea Meiser; Steven Patterson
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

6.  Fragmentation of SIV-gag vaccine induces broader T cell responses.

Authors:  Adel Benlahrech; Andrea Meiser; Shanthi Herath; Timos Papagatsias; Takis Athanasopoulos; Fucheng Li; Steve Self; Veronique Bachy; Catherine Hervouet; Karen Logan; Linda Klavinskis; George Dickson; Steven Patterson
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

7.  Immunogenicity of seven new recombinant yellow fever viruses 17D expressing fragments of SIVmac239 Gag, Nef, and Vif in Indian rhesus macaques.

Authors:  Mauricio A Martins; Myrna C Bonaldo; Richard A Rudersdorf; Shari M Piaskowski; Eva G Rakasz; Kim L Weisgrau; Jessica R Furlott; Christopher M Eernisse; Marlon G Veloso de Santana; Bertha Hidalgo; Thomas C Friedrich; Maria J Chiuchiolo; Christopher L Parks; Nancy A Wilson; David B Allison; Ricardo Galler; David I Watkins
Journal:  PLoS One       Date:  2013-01-15       Impact factor: 3.240

8.  Broadening of the T-cell repertoire to HIV-1 Gag p24 by vaccination of HLA-A2/DR transgenic mice with overlapping peptides in the CAF05 adjuvant.

Authors:  Karen S Korsholm; Ingrid Karlsson; Sheila T Tang; Lea Brandt; Else Marie Agger; Claus Aagaard; Peter Andersen; Anders Fomsgaard
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.